High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: A volumetric intravascular ultrasound study

JACC: Cardiovascular Imaging

Volumn 5, Issue 5, 2012, Pages 540-549

  Chirumamilla, Amala P ^a   Maehara, Akiko ^b,c   Mintz, Gary S ^b   Mehran, Roxana ^b,d   Kanwal, Sunil ^c   Weisz, Giora ^c   Hassanin, Ahmed ^c   Hakim, Diaa ^c   Guo, Ning ^b,c   Baber, Usman ^d   Pyo, Robert ^d   Moses, Jeffrey W ^c   Fahy, Martin ^b   Kovacic, Jason C ^d   Dangas, George D ^b,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; clopidogrel; plaque progression; platelet reactivity; platelets

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG STABILITY; FEMALE; HIGH ON TREATMENT PLATELET REACTIVITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STROKE; THROMBOCYTE FUNCTION; TRANSIENT ISCHEMIC ATTACK;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD PLATELETS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG RESISTANCE; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR CALCIFICATION;

EID: 84861140209     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.12.019     Document Type: Article

References (45)

1. R.A. Lange, L.D. Hillis Antiplatelet therapy for ischemic heart disease N Engl J Med 350 2004 277 280 (Pubitemid 38067641)
2. C. Weber Platelets and chemokines in atherosclerosis: partners in crime Circ Res 96 2005 612 616 (Pubitemid 40478327)
3. J.C. Kovacic, R. Gupta, A.C. Lee Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice J Clin Invest 120 2010 303 314
4. T. Dickfeld, E. Lengyel, A.E. May Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway Implications for atherogenesis Cardiovasc Res 49 2001 189 199
5. M. Gawaz Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium Cardiovasc Res 61 2004 498 511 (Pubitemid 38210155)
6. M. Gawaz, K. Brand, T. Dickfeld Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism Implications for atherogenesis Atherosclerosis 148 2000 75 85
7. M. Gawaz, H. Langer, A.E. May Platelets in inflammation and atherogenesis J Clin Invest 115 2005 3378 3384 (Pubitemid 43121822)
8. Z.M. Ruggeri Platelets in atherothrombosis Nat Med 8 2002 1227 1234 (Pubitemid 35373553)
9. Y. Huo, A. Schober, S.B. Forlow Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E Nat Med 9 2003 61 67 (Pubitemid 36098261)
10. S. Pitsilos, J. Hunt, E.R. Mohler Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters Thromb Haemost 90 2003 1112 1120 (Pubitemid 38004432)
11. J.J. Hathcock Flow effects on coagulation and thrombosis Arterioscler Thromb Vasc Biol 26 2006 1729 1737 (Pubitemid 44305325)
12. Z. Touat, L. Lepage, V. Ollivier Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm Arterioscler Thromb Vasc Biol 28 2008 940 946 (Pubitemid 351544111)
13. C. Gachet Regulation of platelet functions by P2 receptors Annu Rev Pharmacol Toxicol 46 2006 277 300 (Pubitemid 43271191)
14. F.G. Kushner, M. Hand, S.C. Smith Jr 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
15. C. Patrono, C. Baigent, J. Hirsh, G. Roth Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 199S 233S (Pubitemid 351894914)
16. P.A. Gurbel, U.S. Tantry Drug insight: clopidogrel nonresponsiveness Nat Clin Pract Cardiovasc Med 3 2006 387 395 (Pubitemid 43978399)
17. B. Aleil, C. Ravanat, J.P. Cazenave, G. Rochoux, A. Heitz, C. Gachet Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases J Thromb Haemost 3 2005 85 92 (Pubitemid 41647119)
18. P. Barragan, J.L. Bouvier, P.O. Roquebert Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation Catheter Cardiovasc Interv 59 2003 295 302 (Pubitemid 36792384)
19. K.P. Bliden, J. DiChiara, U.S. Tantry, A.K. Bassi, S.K. Chaganti, P.A. Gurbel Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 49 2007 657 666 (Pubitemid 46205039)
20. P.A. Gurbel, R.C. Becker, K.G. Mann, S.R. Steinhubl, A.D. Michelson Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834 (Pubitemid 350007957)
21. P.A. Gurbel, K.P. Bliden, K. Guyer Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study J Am Coll Cardiol 46 2005 1820 1826 (Pubitemid 41579802)
22. P. Järemo, T.L. Lindahl, S.G. Fransson, A. Richter Individual variations of platelet inhibition after loading doses of clopidogrel J Intern Med 252 2002 233 238
23. S. Matetzky, B. Shenkman, V. Guetta Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
24. S.S. Brar, J. ten Berg, R. Marcucci Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
25. F. Mangiacapra, B. De Bruyne, O. Muller High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention J Am Coll Cardiol Intv 3 2010 35 40
26. M.J. Price Bedside evaluation of thienopyridine antiplatelet therapy Circulation 119 2009 2625 2632
27. M.J. Price, P.B. Berger, P.S. Teirstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
28. J. Qian, A. Maehara, G.S. Mintz Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry) Am J Cardiol 103 2009 1210 1214
29. D.J. Angiolillo Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions Diabetes Care 32 2009 531 540
30. U. Baber, R. Mehran, G. Weisz Differences in coronary plaque composition and morphology in patients with and without chronic kidney disease presenting with acute coronary syndromes: insights from the PROSPECT study J Am Coll Cardiol 57 suppl 2011 E1442
31. A.P. Burke, F.D. Kolodgie, A. Farb Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression Circulation 103 2001 934 940 (Pubitemid 32183797)
32. B. Scheuerer, M. Ernst, I. Durrbaum-Landmann The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages Blood 95 2000 1158 1166 (Pubitemid 30099821)
33. P.C. Burger, D.D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2003 2661 2666 (Pubitemid 36857627)
34. S. Fateh-Moghadam, Z. Li, S. Ersel Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2 Arterioscler Thromb Vasc Biol 25 2005 1299 1303 (Pubitemid 40776625)
35. S. Massberg, K. Brand, S. Gruner A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation J Exp Med 196 2002 887 896
36. S. Massberg, K. Schurzinger, M. Lorenz Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb Circulation 112 2005 1180 1188 (Pubitemid 41216125)
37. P. Seizer, M. Gawaz, A.E. May Platelet-monocyte interactions - a dangerous liaison linking thrombosis, inflammation and atherosclerosis Curr Med Chem 15 2008 1976 1980
38. J.M. van Gils, J.J. Zwaginga, P.L. Hordijk Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases J Leukoc Biol 85 2009 195 204
39. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
40. A.D. Michelson, M.D. Linden, M.I. Furman Evidence that pre-existent variability in platelet response to ADP accounts for "clopidogrel resistance." J Thromb Haemost 5 2007 75 81 (Pubitemid 44921070)
41. L. Wexler, B. Brundage, J. Crouse Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications A statement for health professionals from the American Heart Association Circulation 94 1996 1175 1192 (Pubitemid 26292883)
42. A.P. Burke, A. Taylor, A. Farb, G.T. Malcom, R. Virmani Coronary calcification: insights from sudden coronary death victims Z Kardiol 89 2000 49 53
43. J.C. Kovacic, P. Moreno, E.G. Nabel, V. Hachinski, V. Fuster Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly Circulation 123 2011 1900 1910
44. J.C. Kovacic, G.J. Randolph Vascular calcification: harder than it looks Arterioscler Thromb Vasc Biol 31 2011 1249 1250
45. G. Campo, G. Parrinello, P. Ferraresi Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483